GLENN PIERCE
CIK 1256964 · Interim CSO · last filed 2026-06-11
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$76.3K
Companies
2
Total Filings
25
Lifetime Open-Market Net
$28.5K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VYGR | Director | 21,788 | $3.50 | $76.3K | $28.5K | 15 | 2026-06-11 |
| Global Blood Therapeutics, Inc. (GBT) Delisted | Director | 0 | $68.49 | $0 | $0 | 10 | 2022-10-06 |
Recent Filings · Page 3 of 3
25 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-06-30 | VYGR | Grant (A) | — | $0 | EDGAR |
| 2017-06-22 | Global Blood Therapeutics, Inc. (GBT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-01-05 | VYGR | Grant (A) | — | $0 | EDGAR |
| 2016-06-17 | Global Blood Therapeutics, Inc. (GBT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-02-10 | Global Blood Therapeutics, Inc. (GBT) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 21–25 of 25
Prev
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.